Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials-Reference-Cited by-同舟云学术

Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

Published:2017-07 Issue:1 Volume:153 Page:113-122
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Jacobson Ira M.,Lawitz Eric,Gane Edward J.,Willems Bernard E.,Ruane Peter J.,Nahass Ronald G.,Borgia Sergio M.,Shafran Stephen D.,Workowski Kimberly A.,Pearlman Brian,Hyland Robert H.,Stamm Luisa M.,Svarovskaia Evguenia,Dvory-Sobol Hadas,Zhu Yanni,Subramanian G. Mani,Brainard Diana M.,McHutchison John G.,Bräu Norbert,Berg Thomas,Agarwal Kosh,Bhandari Bal Raj,Davis Mitchell,Feld Jordan J.,Dore Gregory J.^ORCID,Stedman Catherine A.M.,Thompson Alexander J.,Asselah Tarik,Roberts Stuart K.,Foster Graham R.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference27 articles.

1. Reinventing HCV treatment: past and future perspectives;Carter;J Clin Pharmacol,2017

2. Treatment of chronic hepatitis C in patients with cirrhosis;Chen;Curr Opin Gastroenterol,2016

3. Oral combination therapies for hepatitis C virus infection: successes, challenges, and unmet needs;Naggie;Annu Rev Med,2017

4. Direct-acting antivirals for the treatment of hepatitis C virus infection: optimizing current IFN-free treatment and future perspectives;Asselah;Liver Int,2016

5. Defining the possibilities: is short duration treatment of chronic hepatitis C genotype 1 with sofosbuvir-containing regimens likely to be as effective as current regimens?;Nafisi;Expert Rev Anti Infect Ther,2016

Cited by 214 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IFNL4 genotype and other personal characteristics to predict response to 8-week sofosbuvir-based treatment for chronic hepatitis C;Journal of Infection;2024-11

2. Cutting-edge pharmacotherapy for hepatitis C virus infection: a comprehensive review;Expert Opinion on Pharmacotherapy;2024-08-12

3. Progress in diagnosis and treatment of hepatitis C;World Chinese Journal of Digestology;2024-07-28

4. The Fixed Dose Combination of Sofosbuvir and Velpatasvir is Safe and Effective in Patients of Chronic Hepatitis C With End-stage Renal Disease;Journal of Clinical and Experimental Hepatology;2024-07

5. Optimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO study;Journal of Hepatology;2024-05